Increasing Community Access to Testing (ICATT)

Award Notice Posted

Solicitation number
75D301-22-C-13957
Agency
Awarded
to Quest Diagnostics Incorporated
Set-aside
No set-aside

Opportunity facts

Contract number
75D301-22-C-13957 Federal contract award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Centers for Disease Control and Prevention announces a $1,142,544,690 contract awarded to Quest Diagnostics Incorporated to significantly increase the availability of COVID-19 testing across the United States through June 1, 2022. The contract, number 75D301-22-C-13957, will enable Quest Diagnostics Incorporated to leverage their private sector laboratory network and scale to provide COVID-19 testing services nationwide to support the CDC Expansion of Screening and Diagnostics Task Force's goal of improving access to community testing.

Notice text

The Expansion of Screening and Diagnostics Task force (ESDTF) at the U.S. Centers for Disease Control and Prevention (CDC), which supports the inter-agency TDWG, seeks to increase equitable access to COVID-19 testing through contractual relationships with private sector partners.

Awarded contract 75D301-22-C-13957 to Quest Diagnostics Incorporated for 1142544690.00 on 2022-06-01.

Notice history

Notice Type Posted
This notice Latest Award Notice
Increasing Community Access to Testing (ICATT) Award Notice
Increasing Community Access to Testing (ICATT) Award Notice
Increasing Community Access to Testing (ICATT) Award Notice
Increasing Community Access to Testing (ICATT) Latest solicitation Solicitation
Increasing Community Access to Testing (ICATT) Original Pre-Solicitation

6 of 8 notices listed here. See the rest on GovTribe.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors